FedBizOpps Reporting Biocryst Received $12,133,606 For BCX4430 NDA Enabling CMC and Non-Clinical Toxicology Studies
July 02, 2015 at 13:34 PM EDT
https://www.fbo.gov/index?s=opportunity&mode=form&id=fe6ad472c84d2b3c6df2960cd9f73ebd&tab=core&_cview=0